![“Qulipta Approved For Preventive Treatment of Episodic Migraine” from MPR]()
by Sue Robbins | Apr 11, 2021 | Migraine
What’s episodic migraine, and how does it differ from a headache? Migraine affects around 40 million people in the United States. It’s often misdiagnosed as sinusitis or other sinus issues, muscle spasms, a primary eye problem, temporomandibular dysfunction, or...
![“Qulipta Approved For Preventive Treatment of Episodic Migraine” from MPR]()
by Sue Robbins | Jul 28, 2020 | Migraine
In patients with episodic migraine, erenumab provided sustained efficacy for the condition over the course of 1 year, according to new results from a study to evaluate the efficacy and safety of erenumab in migraine prevention (STRIVE), published in Neurology....
